https://orcid.org/0000-0003-1480-386X
Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Shambel Araya, Zenebe Gebreyohannes, Getachew Tadlo, Gebreab Teklebirhan Gessew & Abebe Edao Negesso. (2023) Epidemiology and Multidrug Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated from Clinical Samples in Ethiopia. Infection and Drug Resistance 16, pages 2765-2773.
Read now
Read now
Samuel Kariuki, Kelvin Kering, Celestine Wairimu, Robert Onsare & Cecilia Mbae. (2022) Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?. Infection and Drug Resistance 15, pages 3589-3609.
Read now
Read now
Yu-Ting Huang, Chia-I Yu, Pao-Yu Chen, Chi-Chuan Wang & Chien-Chih Wu. (2021) Comparison of Bleeding Risk Between Colistin–Tigecycline and Colistin–Carbapenem Treatment Regimens: A Retrospective Cohort Study. Infection and Drug Resistance 14, pages 4949-4955.
Read now
Read now
Xiao Xu, Caifang Xu, Rabiu Bilya Salisu & Wei Xu. (2021) Beta-Lactamase Gene Expression Level of Hospital-Acquired CRAB Isolated from Children in Picu. Infection and Drug Resistance 14, pages 3195-3205.
Read now
Read now
Hasan Ejaz, Mahtab Ahmad, Sonia Younas, Kashaf Junaid, Khalid Omer Abdalla Abosalif, Abualgasim Elgaili Abdalla, Ayman Ali Mohammed Alameen, Mohammed Yagoub Mohammed Elamir, Syed Nasir Abbas Bukhari, Naveed Ahmad & Muhammad Usman Qamar. (2021) Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring blaNDM and blaOXA From Clinical Origin. Infection and Drug Resistance 14, pages 1931-1939.
Read now
Read now
Nicolette Theriault, Glenn Tillotson & Christian E Sandrock. (2021) Global travel and Gram-negative bacterial resistance; implications on clinical management. Expert Review of Anti-infective Therapy 19:2, pages 181-196.
Read now
Read now
Wanyan Deng, Tiwei Fu, Zhen Zhang, Xiao Jiang, Jianping Xie, Hang Sun, Peng Hu, Hong Ren, Peifu Zhou, Qi Liu & Quanxin Long. (2020) L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake. Emerging Microbes & Infections 9:1, pages 639-650.
Read now
Read now
Articles from other publishers (69)
Margaret Toluwalayo Arowolo, Oluwatosin Qawiyy Orababa, Morufat Oluwatosin Olaitan, Bisola Victoria Osibeluwo, Utibeima Udo Essiet, Olajumoke Hanah Batholomew, Oluwaseyi Gbotoluwa Ogunrinde, Oluwaseyi Aminat Lagoke, Jeffrey Difiye Soriwei, Olanrewaju David Ishola, Onyinye Maryann Ezeani, Aminat Oyeronke Onishile & Elizabeth Olumodeji. (2023) Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis. PLOS ONE 18:11, pages e0287762.
Crossref
Crossref
Niloofar Sadat Tabibpour, Abbas Doosti & Ali Sharifzadeh. (2023) Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii. BMC Immunology 24:1.
Crossref
Crossref
Mehwish Baig, Sana Rahim, Rashid Naseem Khan, Dilroz Dilara Memon, Zaid A Ansari & Muhammad Athar Khan. (2023) Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study. Cureus.
Crossref
Crossref
А. В. Бондаренко, І. В. Чумаченко, О. В. Бондаренко, Д. В. Кацапов, Н. В. Доценко & І. В. Крохмаль. (2023) АЦИНЕТОБАКТЕРНА ІНФЕКЦІЯ У ХВОРИХ НА COVID-19. Інфекційні хвороби:3, pages 55-64.
Crossref
Crossref
Daniela Minerdi, Davide Loqui & Paolo Sabbatini. (2023) Monooxygenases and Antibiotic Resistance: A Focus on Carbapenems. Biology 12:10, pages 1316.
Crossref
Crossref
Hu Jiang, Hengping Pu & Nanqu Huang. (2023) Risk predict model using multi-drug resistant organism infection from Neuro-ICU patients: a retrospective cohort study. Scientific Reports 13:1.
Crossref
Crossref
P. Mihalov, J. Hodosy, A. Koščálová, M. Čaprnda, M. Kachlíková, J. Jurenka, M. Bendžala & P. Sabaka. (2023) Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit. Canadian Journal of Infectious Diseases and Medical Microbiology 2023, pages 1-8.
Crossref
Crossref
Erennur Ugurel & Dilek Turgut-Balik. (2023) Synergistic combination of carvedilol, amlodipine, amitriptyline, and antibiotics as an alternative treatment approach for the susceptible and multidrug-resistant A. baumannii infections via drug repurposing. European Journal of Clinical Microbiology & Infectious Diseases 42:9, pages 1063-1072.
Crossref
Crossref
Amal Sabour. (2023) Global Risk Maps of Climate Change Impacts on the Distribution of Acinetobacter baumannii Using GIS. Microorganisms 11:9, pages 2174.
Crossref
Crossref
Nadezhda K. Fursova, Mikhail V. Fursov, Evgeny I. Astashkin, Anastasiia D. Fursova, Tatiana S. Novikova, Angelina A. Kislichkina, Angelika A. Sizova, Galina N. Fedyukina, Ivan A. Savin & Olga N. Ershova. (2023) Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Causing Nosocomial Meningitis in the Neurological Intensive Care Unit. Microorganisms 11:8, pages 2020.
Crossref
Crossref
Onur Unal, Onur Kaya, Tuba Ozturk, Emel Sesli Cetin, Ibak Gonen, Esra Nurlu Temel & Fusun Zeynep Akcam. (2023)
Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem‐resistant
Acinetobacter baumannii
strain
. Fundamental & Clinical Pharmacology 37:4, pages 816-823.
Crossref
Crossref
Natalia Kolesnik-Goldmann, Helena M. B. Seth-Smith, Klara Haldimann, Frank Imkamp, Tim Roloff, Reinhard Zbinden, Sven N. Hobbie, Adrian Egli & Stefano Mancini. (2023) Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Acinetobacter baumannii. Antibiotics 12:7, pages 1212.
Crossref
Crossref
Heng Kang Ng, Suat Moi Puah, Cindy Shuan Ju Teh, Nuryana Idris & Kek Heng Chua. (2023) Comparative Transcriptomic Profiling of Pellicle and Planktonic Cells from Carbapenem-Resistant Acinetobacter baumannii. Antibiotics 12:7, pages 1185.
Crossref
Crossref
Leocrisia Mwanamoonga, Walter Muleya, Chileshe Lukwesa, Andrew Nalishuwa Mukubesa, Kaunda Yamba, Darlington Mwenya, Ruth Nakazwe, Glory Kashweka, Ladslav Moonga, Bernard Mudenda Hang'ombe & John Bwalya Muma. (2023) Drug-resistant Acinetobacter species isolated at the University Teaching Hospital, Lusaka, Zambia. Scientific African 20, pages e01661.
Crossref
Crossref
Hana Heidarinia, Elahe Tajbakhsh, Mosayeb Rostamian & Hassan Momtaz. (2023) Two peptides derivate from Acinetobacter baumannii outer membrane protein K as vaccine candidates: a comprehensive in silico study. BMC Research Notes 16:1.
Crossref
Crossref
Bianca M. Sorbello, Sarah M. Cahill & Johanna J. Kenyon. (2023) Identification of further variation at the lipooligosaccharide outer core locus in Acinetobacter baumannii genomes and extension of the OCL reference sequence database for Kaptive. Microbial Genomics 9:6.
Crossref
Crossref
Trae Hillyer, Bogdan M. Benin, Chuanqi Sun, Noah Aguirre, Belinda Willard, Yuk Yin Sham & Woo Shik Shin. (2023) A novel strategy to characterize the pattern of β-lactam antibiotic-induced drug resistance in Acinetobacter baumannii. Scientific Reports 13:1.
Crossref
Crossref
Ji Hyeon Lee, Joon Kim & Ga-Yeon Kim. (2023) Synergistic Effects of a Probiotic Culture Extract and Antimicrobial Combinations against Multidrug-Resistant Acinetobacter baumannii. Medicina 59:5, pages 947.
Crossref
Crossref
Naser Nasiri, Ali Sharifi, Iman Ghasemzadeh, Malahat Khalili, Ali Karamoozian, Ali Khalooei, Amin Beigzadeh, AliAkbar Haghdoost & Hamid Sharifi. (2023) Incidence, accuracy, and barriers of diagnosing healthcare-associated infections: a case study in southeast Iran. BMC Infectious Diseases 23:1.
Crossref
Crossref
Marta Gomes, Rita Domingues, Dann Turner & Hugo Oliveira. (2023) Genomic Analysis of Two Novel Bacteriophages Infecting Acinetobacter beijerinckii and halotolerans Species. Viruses 15:3, pages 643.
Crossref
Crossref
Yayun Zhao, Yunzhu Zhu, Hui Zhang, Lingyan Zhang, Jiabin Li & Ying Ye. (2023) Molecular tracking of carbapenem-resistant Acinetobacter baumannii clinical isolates: a multicentre study over a 4-year period across eastern China. Journal of Medical Microbiology 72:2.
Crossref
Crossref
Yuce Chen, Zhen Li, Yu Yin, Ping Yang, Yijin Kong, Zhong Li, Daijie Chen & Xiaoyong Xu. (2023) Identification of 2-aminothiazoyl piperidine derivatives as a new class of adjuvants potentiating the activity of colistin against Acinetobacter baumannii. Chinese Chemical Letters 34:2, pages 107948.
Crossref
Crossref
Mecky Matee, Stephen E. Mshana, Majigo Mtebe, Erick Vitus Komba, Nyambura Moremi, Julius Lutamwa, Otrida Kapona, Musa Sekamatte & Leonard E. G. Mboera. (2023) Mapping and gap analysis on antimicrobial resistance surveillance systems in Kenya, Tanzania, Uganda and Zambia. Bulletin of the National Research Centre 47:1.
Crossref
Crossref
Rayan I Aloraifi, Abdullah F Alharthi, Abdulrahman A Almefleh, Abdulkhaleq H Alamri, Adi S Alobud, Reema A Bawazeer, Abdulrahman A Alswaji, Bassam Alalwan, Marwh G Aldriwesh, Sameera M Al Johani & Majed F Alghoribi. (2023) Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia. Cureus.
Crossref
Crossref
Wafaa H. Elwakil, Soha S. Rizk, Ali M. El-Halawany, Mostafa E. Rateb & Ahmed S. Attia. (2023) Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions. Antibiotics 12:1, pages 77.
Crossref
Crossref
Rasha Hatem Shayea & Munim Radwan Ali. (2023)
Whole-genome Study of Carbapenem-resistant
Acinetobacter baumannii
Virulence and Resistance
. Iranian Journal of Medical Microbiology 17:1, pages 90-102.
Crossref
Crossref
Raja Singh & Vibha Tandon. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
583
619
.
Irina Buchovec, Enrika Vyčaitė, Kazimieras Badokas, Edita Sužiedelienė & Saulius Bagdonas. (2022) Application of Antimicrobial Photodynamic Therapy for Inactivation of Acinetobacter baumannii Biofilms. International Journal of Molecular Sciences 24:1, pages 722.
Crossref
Crossref
Joseph Elikem Efui Acolatse, Edward A. R. Portal, Ian Boostrom, George Akafity, Mavis Puopelle Dakroah, Victoria J. Chalker, Kirsty Sands & Owen B. Spiller. (2022) Environmental surveillance of ESBL and carbapenemase-producing gram-negative bacteria in a Ghanaian Tertiary Hospital. Antimicrobial Resistance & Infection Control 11:1.
Crossref
Crossref
Anja von Laer, Tim Eckmanns, Benedikt Zacher, Niels Pfennigwerth, Sören G. Gatermann, Felix Reichert, Michaela Diercke, Gyde Steffen, Doris Altmann & Annicka Reuss. (2022) Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019. Antimicrobial Resistance & Infection Control 11:1.
Crossref
Crossref
Harald Seifert, Joseph Blondeau, Kai Lucaßen & Eric A. Utt. (2022) Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018). Journal of Global Antimicrobial Resistance 31, pages 82-89.
Crossref
Crossref
Flora Cruz-López, Adrián Martínez-Meléndez, Licet Villarreal-Treviño, Rayo Morfín-Otero, Héctor Maldonado-Garza & Elvira Garza-González. (2022) Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii. The American Journal of the Medical Sciences 364:6, pages 685-694.
Crossref
Crossref
Hasan Ejaz, Muhammad Usman Qamar, Kashaf Junaid, Sonia Younas, Zeeshan Taj, Syed Nasir Abbas Bukhari, Abualgasim E. Abdalla, Khalid O. A. Abosalif, Naveed Ahmad, Zikria Saleem & Eman H. M. Salem. (2022) The Molecular Detection of Class B and Class D Carbapenemases in Clinical Strains of Acinetobacter calcoaceticus-baumannii Complex: The High Burden of Antibiotic Resistance and the Co-Existence of Carbapenemase Genes. Antibiotics 11:9, pages 1168.
Crossref
Crossref
Shruti Kashyap, Harsimran Sidhu, Prince Sharma & Neena Capalash. (2022)
3-indoleacetonitrile attenuates biofilm formation and enhances sensitivity to imipenem in
Acinetobacter baumannii
. Pathogens and Disease 80:1.
Crossref
Crossref
Shuk-Ching Wong, Pui-Hing Chau, Simon Yung-Chun So, Germaine Kit-Ming Lam, Veronica Wing-Man Chan, Lithia Lai-Ha Yuen, Christine Ho-Yan Au Yeung, Jonathan Hon-Kwan Chen, Pak-Leung Ho, Kwok-Yung Yuen & Vincent Chi-Chung Cheng. (2022) Control of Healthcare-Associated Carbapenem-Resistant Acinetobacter baumannii by Enhancement of Infection Control Measures. Antibiotics 11:8, pages 1076.
Crossref
Crossref
Shahriar Sepahvand, Mohammad Darvishi, Maral Mokhtari & Mohammad Ali Davarpanah. (2022)
Evaluation of genetic diversity of colistin-resistant
Acinetobacter baumannii
by BOX-PCR and ERIC-PCR: the first report
. Future Microbiology 17:12, pages 917-930.
Crossref
Crossref
Gathoni Kamuyu, Giuseppe Ercoli, Elisa Ramos-Sevillano, Sam Willcocks, Chidchamai Kewcharoenwong, Pattarachai Kiratisin, Peter W. Taylor, Brendan W. Wren, Ganjana Lertmemongkolchai, Richard A. Stabler & Jeremy S. Brown. (2022) Strain Specific Variations in Acinetobacter baumannii Complement Sensitivity. Frontiers in Immunology 13.
Crossref
Crossref
Diogo Filipe Borges Duarte & Acácio Gonçalves Rodrigues. (2022)
Acinetobacter baumannii
: insights towards a comprehensive approach for the prevention of outbreaks in health‐care facilities
. APMIS 130:6, pages 330-337.
Crossref
Crossref
Kevin Antraygues, Nina Compagne, Francesca Ruggieri, Kamel Djaout, Zainab Edoo, Maxime Eveque, Léo Faïon, Bruna Gioia, Salia Tangara, Anais Vieira Da Cruz, Baptiste Villemagne, Marion Flipo, Alain Baulard & Nicolas Willand. (2022) On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9–10 December 2021. Pharmaceuticals 15:4, pages 388.
Crossref
Crossref
Dewi Anggraini, Dewi Santosaningsih, Yulia Rosa Saharman, Pepy Dwi Endraswari, Cahyarini Cahyarini, Leli Saptawati, Zinatul Hayati, Helmia Farida, Cherry Siregar, Munawaroh Pasaribu, Heriyannis Homenta, Enty Tjoa, Novira Jasmin, Rosantia Sarassari, Wahyu Setyarini, Usman Hadi & Kuntaman Kuntaman. (2022) Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study. Antibiotics 11:3, pages 366.
Crossref
Crossref
Phitchayapak Wintachai, Narumon Phaonakrop, Sittiruk Roytrakul, Ampapan Naknaen, Rattanaruji Pomwised, Supayang Piyawan Voravuthikunchai, Komwit Surachat & Duncan R. Smith. (2022) Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii. Scientific Reports 12:1.
Crossref
Crossref
Samantha Palethorpe, John M. FarrowIIIIII, Greg Wells, Morgan E. Milton, Luis A. Actis, John Cavanagh & Everett C. Pesci. (2022) Acinetobacter baumannii Regulates Its Stress Responses via the BfmRS Two-Component Regulatory System. Journal of Bacteriology 204:2.
Crossref
Crossref
Kirti Upmanyu, Qazi Mohd. Rizwanul Haq & Ruchi Singh. (2022) Factors mediating Acinetobacter baumannii biofilm formation: Opportunities for developing therapeutics. Current Research in Microbial Sciences 3, pages 100131.
Crossref
Crossref
Samantha Palethorpe, Morgan E Milton, Everett C Pesci & John Cavanagh. (2021)
Structure of the
Acinetobacter baumannii
PmrA receiver domain and insights into clinical mutants affecting DNA binding and promoting colistin resistance
. The Journal of Biochemistry 170:6, pages 787-800.
Crossref
Crossref
Dunja Said, Niklas Willrich, Olaniyi Ayobami, Ines Noll, Tim Eckmanns & Robby Markwart. (2021) The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system. Antimicrobial Resistance & Infection Control 10:1.
Crossref
Crossref
Yanpeng Zhang, Bing Fan, Yong Luo, Zhiyuan Tao, Yongbo Nie, Yongtao Wang, Fanglin Ding, Yanwu Li & Dayong Gu. (2021) Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility. BMC Infectious Diseases 21:1.
Crossref
Crossref
Gamal Wareth, Christian Brandt, Lisa D. Sprague, Heinrich Neubauer & Mathias W. Pletz. (2021) WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective. BMC Microbiology 21:1.
Crossref
Crossref
Ayman Kharaba, Haifa Algethamy, Mohamed Hussein, Fahad M. Al-Hameed, Adnan Alghamdi, Ammar Hamdan, Jehan Fatani, Alyaa Elhazmi, Hassan Alkhalaf, Basem Barghash, Ahmad Elsawy & Yaseen M. Arabi. (2021) Incidence, outcomes, and predictors of Acinetobacter infection in Saudi Arabian critical care units. Journal of Critical Care 66, pages 109-116.
Crossref
Crossref
Mai M. Zafer, Amira F. A. Hussein, Mohamed H. Al-Agamy, Hesham H. Radwan & Samira M. Hamed. (2021) Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel blaADC-257. Frontiers in Microbiology 12.
Crossref
Crossref
Seok-Hyeon Na, Hyejin Jeon, Man-Hwan Oh, Yoo-Jeong Kim, Mingi Chu, Ill-Young Lee & Je-Chul Lee. (2021) Therapeutic Effects of Inhibitor of ompA Expression against Carbapenem-Resistant Acinetobacter baumannii Strains. International Journal of Molecular Sciences 22:22, pages 12257.
Crossref
Crossref
Simon Brinkwirth, Olaniyi Ayobami, Tim Eckmanns & Robby Markwart. (2021) Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020. Eurosurveillance 26:45.
Crossref
Crossref
Shruti Kashyap, Prince Sharma & Neena Capalash. (2021) Potential genes associated with survival of Acinetobacter baumannii under ciprofloxacin stress. Microbes and Infection 23:9-10, pages 104844.
Crossref
Crossref
Yu-Chia Hsieh, Jia-Wen Wu, Yi-Yin Chen, Tran Lam Tu Quyen, Wei-Chao Liao, Shiao-Wen Li, Yin-Cheng Chen & Yi-Jiun Pan. (2021) An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan. Antibiotics 10:10, pages 1239.
Crossref
Crossref
Karyne Rangel, Thiago Pavoni Gomes Chagas & Salvatore Giovanni De-Simone. (2021) Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. Pathogens 10:8, pages 1006.
Crossref
Crossref
Sílvia A. Sousa, Joana R. Feliciano, Tiago Pita, Catarina F. Soeiro, Beatriz L. Mendes, Luis G. Alves & Jorge H. Leitão. (2021) Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials. Antibiotics 10:8, pages 942.
Crossref
Crossref
A.P. Uber, G.F. Viana, F.G. Lodi, M.M. Anjos Szczerepa, F.E. Carrara‐Marroni, F. Gimenes, S.A.B. Nishiyama & M.C.B. Tognim. (2021)
Adherence ability and serum resistance of different hospital clusters of
Acinetobacter baumannii
. Letters in Applied Microbiology 73:2, pages 132-138.
Crossref
Crossref
Hyeri Seok, Ji Hoon Jeon, Ji Hye Jung, Sang Hee Ahn, Minji Seo, Hyun Kyung Cho, Sul A Sung, Su-Hyun Kim, Hee Kyoung Choi, Won Suk Choi & Dae Won Park. (2021) Does enhanced environmental cleaning reduce carbapenem-resistant Acinetobacter baumannii colonization in the intensive care unit?. International Journal of Infectious Diseases 109, pages 72-76.
Crossref
Crossref
Lucia Bonadonna, Rossella Briancesco, Anna Maria Coccia, Pierluigi Meloni, Giuseppina La Rosa & Umberto Moscato. (2021) Microbial Air Quality in Healthcare Facilities. International Journal of Environmental Research and Public Health 18:12, pages 6226.
Crossref
Crossref
Phillip E. Klebba, Salete M. C. Newton, David A. Six, Ashish Kumar, Taihao Yang, Brittany L. Nairn, Colton Munger & Somnath Chakravorty. (2021) Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics. Chemical Reviews 121:9, pages 5193-5239.
Crossref
Crossref
Shruti Kashyap, Sukhvir Kaur, Prince Sharma & Neena Capalash. (2021) Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps. Microbes and Infection 23:4-5, pages 104795.
Crossref
Crossref
Ziv Dadon, Eli Ben-Chetrit, Ofer Benjaminov, Louay Taha, Yonit Wiener-Well, Daniel Belman & Phillip D. Levin. (2021) The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients. Clinical Microbiology and Infection 27:4, pages 635.e1-635.e4.
Crossref
Crossref
Jūratė Skerniškytė, Emilija Karazijaitė, Asta Lučiūnaitė & Edita Sužiedėlienė. (2021) OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response. Pathogens 10:4, pages 407.
Crossref
Crossref
Mahyar Porbaran, Hamed Tahmasebi & MohammadReza Arabestani. (2021) A Comprehensive Study of the Relationship between the Production of β-Lactamase Enzymes and Iron/Siderophore Uptake Regulatory Genes in Clinical Isolates of Acinetobacter baumannii. International Journal of Microbiology 2021, pages 1-8.
Crossref
Crossref
Wail A Hayajneh, Sayer Al-Azzam, Dawood Yusef, William J Lattyak, Elizabeth A Lattyak, Ian Gould, José-María López-Lozano, Barbara R Conway, Geraldine Conlon-Bingham & Mamoon A Aldeyab. (2021)
Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant
Acinetobacter baumannii
(CRAb) incidence rates in hospitalized patients in Jordan
. Journal of Antimicrobial Chemotherapy 76:2, pages 524-530.
Crossref
Crossref
Ghayda Al-HashemVincent O. RotimiM. John Albert. (2021)
Antimicrobial Resistance of Serial Isolates of
Acinetobacter baumannii
Colonizing the Rectum of Adult Intensive Care Unit Patients in a Teaching Hospital in Kuwait
. Microbial Drug Resistance 27:1, pages 64-72.
Crossref
Crossref
Olaniyi Ayobami, Niklas Willrich, Beneditta Suwono, Tim Eckmanns & Robby Markwart. (2020) The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
Jingyi Shi, Ting Sun, Yun Cui, Chunxia Wang, Fei Wang, Yiping Zhou, Huijie Miao, Yijun Shan & Yucai Zhang. (2020) Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infectious Diseases 20:1.
Crossref
Crossref
Wasan Katip, Suriyon Uitrakul & Peninnah Oberdorfer. (2020) A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis. Antibiotics 9:10, pages 647.
Crossref
Crossref
Kyungmin Huh, Doo Ryeon Chung, Young Eun Ha, Jae-Hoon Ko, Si-Ho Kim, Min-Ji Kim, Hee Jae Huh, Nam Yong Lee, Sun Young Cho, Cheol-In Kang, Kyong Ran Peck & Jae-Hoon Song. (2020) Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data. Clinical Infectious Diseases.
Crossref
Crossref